Baillie Gifford & Co’s Cellectis CLLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-139,047
Closed -$172K 267
2025
Q1
$172K Sell
139,047
-151,382
-52% -$224K ﹤0.01% 250
2024
Q4
$523K Sell
290,429
-403,510
-58% -$753K ﹤0.01% 249
2024
Q3
$1.49M Sell
693,939
-13,691
-2% -$29.7K ﹤0.01% 245
2024
Q2
$1.32M Sell
707,630
-119,618
-14% -$314K ﹤0.01% 250
2024
Q1
$2.19M Buy
827,248
+10,605
+1% +$29.3K ﹤0.01% 247
2023
Q4
$2.52M Sell
816,643
-347,366
-30% -$824K ﹤0.01% 251
2023
Q3
$1.84M Sell
1,164,009
-254,987
-18% -$498K ﹤0.01% 254
2023
Q2
$2.8M Sell
1,418,996
-220,900
-13% -$424K ﹤0.01% 248
2023
Q1
$3.16M Buy
1,639,896
+1,040,000
+173% +$2.6M ﹤0.01% 249
2022
Q4
$1.26M Sell
599,896
-188,941
-24% -$428K ﹤0.01% 268
2022
Q3
$1.81M Sell
788,837
-92,095
-10% -$279K ﹤0.01% 262
2022
Q2
$2.49M Sell
880,932
-201,163
-19% -$708K ﹤0.01% 261
2022
Q1
$4.91M Buy
1,082,095
+2,584
+0.2% +$14.2K ﹤0.01% 252
2021
Q4
$8.77M Buy
1,079,511
+2,986
+0.3% +$29.4K ﹤0.01% 250
2021
Q3
$13.6M Buy
1,076,525
+42,653
+4% +$591K 0.01% 235
2021
Q2
$16M Buy
+1,033,872
New +$17.4M 0.01% 235

Other funds holding CLLS

Baillie Gifford & Co's CLLS Position: Q2 2025 in Review

Baillie Gifford & Co sold out of Cellectis (CLLS) in Q2 2025, closing a stake of 139,047 shares — an estimated $172K sold.

Baillie Gifford & Co first reported a position in CLLS in Q2 2021 and held it in 16 quarters. The position peaked at $16M in Q2 2021. 24 funds tracked by Wall St. Rank hold CLLS as of Q2 2025.

  • Baillie Gifford & Co reported no remaining Cellectis position as of Q2 2025 after selling out during the quarter.
  • Baillie Gifford & Co sold 139,047 Cellectis shares in Q2 2025, an estimated $172K.
  • Baillie Gifford & Co first reported a position in Cellectis in Q2 2021 and held it in 16 quarters.
  • Baillie Gifford & Co's Cellectis position peaked at $16M in Q2 2021.
  • 24 funds tracked by Wall St. Rank held Cellectis as of Q2 2025.

Based on Baillie Gifford & Co's 13F filing for Q2 2025, filed 6 Aug 2025.